Concepedia

Catherine Buontempo

CB

3

Publications

143

Citations

3

H-Index

2006

Active since

Affiliations

BioPhage Pharma (Canada)(Current)

Catherine Buontempo is an author at BioPhage Pharma (Canada) specializing in virology, immunology, and hiv.

Top concepts

Publications per year

2006–2009

3

Publications

3

Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120

Robert A. Ogert, Lisa Wojcik, Catherine Buontempo et al. · Virology · 2008 · 89 citations

, , +7

Structure-Function Analysis of Human Immunodeficiency Virus Type 1 gp120 Amino Acid Mutations Associated with Resistance to the CCR5 Coreceptor Antagonist Vicriviroc

Robert A. Ogert, Lei Ba, Yan Hou et al. · Journal of Virology · 2009 · 32 citations · Full text

, , +15

Antiviral Activity of Transiently Expressed IFN-κ Is Cell-Associated

Peter Buontempo, Ronald Jubin, Catherine Buontempo et al. · Journal of Interferon & Cytokine Research · 2006 · 22 citations

Rows per page

1–3 of 3